It is not healthy: Mending the broken medicines innovation model

[December 02, 2015]
European Parliament, Brussels, Belgium

 

Organized by the Transatlantic Consumer Dialogue (TACD), the European Public Health Alliance (EPHA), Médecins du Monde (MdM) International network, Universities Allied for Essential Medicines (UAEM Europe), Salud Por Derecho, in collaboration with the European Parliament Working Group on innovation, access to medicines & poverty-related diseases.

Dr Bernard Pécoul, Executive Director of DNDi, will be speaking in a Q&A Session entitled: What are some of the possible cures for our ailing and expensive pharmaceutical model?

 

Discussion

Date: December 2, 2015

Venue: European Parliament, Rue Wiertz 60, 1047 Bruxelles, Belgium

 

What is the diagnosis for our medical innovation and medicines pricing ills?

Speakers:

  • Xavier Prats Monné, Director-General, DG SANTE, European Commission (to be confirmed)
  • Teresa Alves, International Policy Adviser, La Revue Prescrire
  • Dr Fernando Lamata, @LamataF,Consejería de Sanidad de la Comunidad de Madrid, Madrid, Spain – member of the EC’s Expert Panel Working Group on access to health care
  • Dr Antje Haas, Head of pharmaceuticals department, GKV – Spitzenverband
 Q&A Session


What are some of the possible cures for our ailing and expensive pharmaceutical model?

Speakers:

  • Rachel Kiddell-Monroe, Special Advisor, Universities Allied for Essential Medicines
  • Dr Bernard Pécoul, Executive Director, Drugs for Neglected Diseases initiative (DNDi)
  • Els Toreele, Director, Open Society Public Health Program, Access to Essential Medicines Initiative